Skip to main content
PACB
NASDAQ Life Sciences

PacBio Posts 12-Cent Quarterly Loss as Turnaround Pressure Mounts

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$2.57
Mkt Cap
$792.618M
52W Low
$1.07
52W High
$3.435
52W Position info
140% above low
Off High info
25% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

PACB has more than doubled off its 52-week low of $1.07.

Summary

PacBio reported a third-quarter loss of $37.8M, or 12 cents per share, on revenue of $40.6M. That lands after a rough stretch: Q2 revenue of $39.0M missed estimates in August, the company set its 2026 revenue outlook at $155M–$160M, and it pushed cash-flow breakeven further out. The new CEO, Mark Van Oene, is running a restructuring aimed at cutting $30M-$40M in annual costs, and the CFO has been selling shares under a pre-arranged 10b5-1 plan. With the stock at $2.57 and a market cap under $800M, the loss keeps the focus squarely on cash burn and whether the cost cuts land fast enough.

At the time of this announcement, PACB was trading at $2.57 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $792.6M. The 52-week trading range was $1.07 to $3.44. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

PACB - Latest Insights

PACB
Nov 10, 2026, 4:05 PM EST
Filing Type: 424B5
Importance Score:
7
Price at Filing: $2.25
Real-time Price: $1.66 info
Change: -$0.589 (-26%) info
Market Cap: $519.458M info
PACB
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.54
Real-time Price: $1.66 info
Change: -$0.880 (-35%) info
Market Cap: $519.458M info
PACB
Nov 04, 2026, 5:41 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.60
Real-time Price: $1.66 info
Change: -$0.940 (-36%) info
Market Cap: $519.458M info
PACB
Nov 04, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.68
Real-time Price: $1.66 info
Change: -$1.02 (-38%) info
Market Cap: $519.458M info
PACB
Aug 06, 2026, 5:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.16
Real-time Price: $1.66 info
Change: +$0.500 (+43%) info
Market Cap: $519.458M info